cv 6504 has been researched along with linoleic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bibby, MC; Hussey, HJ; Tisdale, MJ | 1 |
| Anderson, DA; Baddeley, J; Bramhall, S; Buckels, J; Daryanani, S; Deakin, M; Doran, J; Ferry, DR; Kerr, DJ; Pemberton, G; Wakelam, MJ; Young, AM | 1 |
| Tisdale, MJ; Whitehouse, AS | 1 |
1 trial(s) available for cv 6504 and linoleic acid
| Article | Year |
|---|---|
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints.
Topics: Antineoplastic Agents; Benzoquinones; Disease Progression; Disease-Free Survival; Drug Evaluation; Female; Humans; Linoleic Acid; Lipoxygenase Inhibitors; Male; Middle Aged; Pancreatic Neoplasms; Thromboxane B2 | 2000 |
2 other study(ies) available for cv 6504 and linoleic acid
| Article | Year |
|---|---|
Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Benzoquinones; Cell Division; Colonic Neoplasms; Growth Inhibitors; Linoleic Acid; Linoleic Acids; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains | 1996 |
Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
Topics: Acute Disease; Adenosine Triphosphatases; Administration, Oral; Animals; Benzoquinones; Cysteine Endopeptidases; Docosahexaenoic Acids; Eicosapentaenoic Acid; Endopeptidases; Enzyme Activation; Female; In Vitro Techniques; Linoleic Acid; Lipoxygenase Inhibitors; Mice; Mice, Inbred Strains; Multienzyme Complexes; Muscle, Skeletal; Proteasome Endopeptidase Complex; Signal Transduction; Starvation; Ubiquitins | 2001 |